NM_007126.5:c.1360-35A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_007126.5(VCP):c.1360-35A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.765 in 1,613,946 control chromosomes in the GnomAD database, including 475,673 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.75 ( 43403 hom., cov: 32)
Exomes 𝑓: 0.77 ( 432270 hom. )
Consequence
VCP
NM_007126.5 intron
NM_007126.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.536
Publications
20 publications found
Genes affected
VCP (HGNC:12666): (valosin containing protein) This gene encodes a member of the AAA ATPase family of proteins. The encoded protein plays a role in protein degradation, intracellular membrane fusion, DNA repair and replication, regulation of the cell cycle, and activation of the NF-kappa B pathway. This protein forms a homohexameric complex that interacts with a variety of cofactors and extracts ubiquitinated proteins from lipid membranes or protein complexes. Mutations in this gene cause IBMPFD (inclusion body myopathy with paget disease of bone and frontotemporal dementia), ALS (amyotrophic lateral sclerosis) and Charcot-Marie-Tooth disease in human patients. [provided by RefSeq, Aug 2017]
VCP Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- inclusion body myopathy with Paget disease of bone and frontotemporal dementiaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Charcot-Marie-Tooth disease type 2YInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- frontotemporal dementia and/or amyotrophic lateral sclerosis 6Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- adult-onset distal myopathy due to VCP mutationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- frontotemporal dementia with motor neuron diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- spastic paraplegia-Paget disease of bone syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 9-35060958-T-C is Benign according to our data. Variant chr9-35060958-T-C is described in ClinVar as Benign. ClinVar VariationId is 260123.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.783 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| VCP | NM_007126.5 | c.1360-35A>G | intron_variant | Intron 11 of 16 | ENST00000358901.11 | NP_009057.1 | ||
| VCP | NM_001354927.2 | c.1225-35A>G | intron_variant | Intron 11 of 16 | NP_001341856.1 | |||
| VCP | NM_001354928.2 | c.1225-35A>G | intron_variant | Intron 11 of 16 | NP_001341857.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.753 AC: 114391AN: 151982Hom.: 43374 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
114391
AN:
151982
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.748 AC: 188166AN: 251462 AF XY: 0.746 show subpopulations
GnomAD2 exomes
AF:
AC:
188166
AN:
251462
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.767 AC: 1120704AN: 1461846Hom.: 432270 Cov.: 80 AF XY: 0.766 AC XY: 556761AN XY: 727222 show subpopulations
GnomAD4 exome
AF:
AC:
1120704
AN:
1461846
Hom.:
Cov.:
80
AF XY:
AC XY:
556761
AN XY:
727222
show subpopulations
African (AFR)
AF:
AC:
25033
AN:
33480
American (AMR)
AF:
AC:
37621
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
20668
AN:
26136
East Asian (EAS)
AF:
AC:
19534
AN:
39700
South Asian (SAS)
AF:
AC:
61506
AN:
86250
European-Finnish (FIN)
AF:
AC:
38401
AN:
53410
Middle Eastern (MID)
AF:
AC:
4306
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
868196
AN:
1111986
Other (OTH)
AF:
AC:
45439
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
18445
36889
55334
73778
92223
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20526
41052
61578
82104
102630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.753 AC: 114472AN: 152100Hom.: 43403 Cov.: 32 AF XY: 0.748 AC XY: 55622AN XY: 74336 show subpopulations
GnomAD4 genome
AF:
AC:
114472
AN:
152100
Hom.:
Cov.:
32
AF XY:
AC XY:
55622
AN XY:
74336
show subpopulations
African (AFR)
AF:
AC:
30674
AN:
41474
American (AMR)
AF:
AC:
12156
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
2762
AN:
3470
East Asian (EAS)
AF:
AC:
2384
AN:
5160
South Asian (SAS)
AF:
AC:
3411
AN:
4818
European-Finnish (FIN)
AF:
AC:
7589
AN:
10562
Middle Eastern (MID)
AF:
AC:
225
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53056
AN:
68016
Other (OTH)
AF:
AC:
1572
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1447
2893
4340
5786
7233
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
852
1704
2556
3408
4260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2031
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Charcot-Marie-Tooth disease type 2Y Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.